{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T14:10:03Z","timestamp":1753884603945},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Stent designs with ultrathin struts may further increase the procedural success of challenging lesion subsets. The objective of this study was to assess the safety and efficacy of ultrathin strut, polymer-free sirolimus eluting stent (PF-SES) implantations in a large scale, unselected patient population.<\/jats:p>\n            <jats:p>Adult patients underwent percutaneous coronary interventions (PCI) with a thin-strut PF-SES. Data from two all-comers observational studies having the same protocol (ClinicalTrials.gov Identifiers: NCT02629575 and NCT02905214) were pooled. The accumulated target lesion revascularization (TLR) rate at 9-12 months was the primary endpoint. All dual antiplatelet therapy strategies according to the applicable guidelines were permissible.<\/jats:p>\n            <jats:p>In total, 7243 patients were prospectively enrolled for PCI with PF-SES in stable coronary artery disease or acute coronary syndrome (ACS). Major risk factors in the overall cohort were diabetes (37.3%), ST elevation myocardial infarction (18.1%) and non-ST myocardial infarction (24.6%). The follow-up rate was 88.6% in the overall population. The TLR rate in the overall cohort was 2.2% whereas definite\/probable stent thrombosis (ST) occurred in 0.7%. In patients with in-stent restenosis lesions, the major adverse cardiac events rate was 6.4% whereas the corresponding rate for isolated left main coronary artery (LMCA) disease was highest with 6.7% followed by patients with culprit lesions in vein bypasses (VB, 7.1%). The mortality rate in patients treated in VB lesions was highest with 5.4%, followed by the isolated LMCA subgroup (3.4%) and ACS (2.6%).<\/jats:p>\n            <jats:p>PCI with PF-SES in an unselected patient population, is associated with low clinical event and ST rates. Furthermore, PF-SES angioplasty in niche indications demonstrated favorable safety and efficacy outcomes with high procedural success rates.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019119","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T04:53:44Z","timestamp":1582260824000},"page":"e19119","source":"Crossref","is-referenced-by-count":5,"title":["Unrestricted use of polymer-free sirolimus eluting stents in routine clinical practice"],"prefix":"10.1097","volume":"99","author":[{"given":"Florian","family":"Krackhardt","sequence":"first","affiliation":[{"name":"Department of Internal Medicine and Cardiology, Charite\u0301 \u2013 Universita\u0308tsmedizin Berlin, Campus Virchow Klinikum, Berlin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Ko\u010dka","sequence":"additional","affiliation":[{"name":"University Hospital Kr\u00e1lovsk\u00e9 Vinohrady Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Waliszewski","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Cardiology, Charite\u0301 \u2013 Universita\u0308tsmedizin Berlin, Campus Virchow Klinikum, Berlin"},{"name":"Medical Scientific Affairs, B.Braun Melsungen AG, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Tou\u0161ek","sequence":"additional","affiliation":[{"name":"University Hospital Kr\u00e1lovsk\u00e9 Vinohrady Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bronislav","family":"Janek","sequence":"additional","affiliation":[{"name":"IKEM Prague, Czech Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Tren\u010dan","sequence":"additional","affiliation":[{"name":"S\u00daSCCH, a.s. Bansk\u00e1 Bystrica, Slovak Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kraj\u010di","sequence":"additional","affiliation":[{"name":"S\u00daSCCH, a.s. Bansk\u00e1 Bystrica, Slovak Republic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Lozano","sequence":"additional","affiliation":[{"name":"Hospital General Universitario de Ciudad Real, Ciudad Real"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koldobika Garcia-San","family":"Roman","sequence":"additional","affiliation":[{"name":"Hospital Universitario de Cruces, Bilbao"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imanol","family":"Otaegui","sequence":"additional","affiliation":[{"name":"Hospital Universitari Vall d\u2019Hebron"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Garcia","family":"del Blanco","sequence":"additional","affiliation":[{"name":"Hospital Universitari Vall d\u2019Hebron"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria Vilalta","family":"del Olmo","sequence":"additional","affiliation":[{"name":"Hospital Universitari Germans Trias i Pujol, Badalona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard Fernandez","family":"Nofrer\u00edas","sequence":"additional","affiliation":[{"name":"Hospital Universitari Germans Trias i Pujol, Badalona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Wachowiak","sequence":"additional","affiliation":[{"name":"Medical Scientific Affairs, B.Braun France, Saint Cloud, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tay Mok","family":"Heang","sequence":"additional","affiliation":[{"name":"Pantai Ayer Keroh Hospital, Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Hoon","family":"Ahn","sequence":"additional","affiliation":[{"name":"Gachon University Gil Medical Center, Incheon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Ho","family":"Jeong","sequence":"additional","affiliation":[{"name":"Chonnam National University, Gwangju"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Chun","family":"Jung","sequence":"additional","affiliation":[{"name":"Daegu Fatima Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu-Rock","family":"Han","sequence":"additional","affiliation":[{"name":"Kangdong Sacred Heart Hospital, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Piot","sequence":"additional","affiliation":[{"name":"Clinique du Mill\u00e9naire, Montpellier"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Sebagh","sequence":"additional","affiliation":[{"name":"Clinique Turin Paris"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Rischner","sequence":"additional","affiliation":[{"name":"H\u00f4pital Albert Schweitzer Colmar"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Pansieri","sequence":"additional","affiliation":[{"name":"Centre Hospitalier d\u2019Avignon, Avignon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Leschke","sequence":"additional","affiliation":[{"name":"St\u00e4dtische Kliniken Esslingen, Esslingen, Germany."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,2]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"e006741","DOI":"10.1161\/CIRCINTERVENTIONS.118.006741","article-title":"Unselected use of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for coronary revascularization","volume":"11","author":"Yamaji","year":"2018","journal-title":"Circ Cardiovasc Interv"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jcin.2018.12.036","article-title":"SORT OUT VIII investigators. Everolimus-eluting versus biolimus-eluting stents with biodegradable polymers in unselected patients undergoing percutaneous coronary intervention: a randomized noninferiority trial with 1-year follow-up (SORT OUT VIII Trial)","volume":"12","author":"Maeng","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"e000592","DOI":"10.1136\/openhrt-2017-000592","article-title":"Polymer-free sirolimus-eluting stents in a large-scale all-comers population","volume":"4","author":"Krackhardt","year":"2017","journal-title":"Open Heart"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/ccd.27306","article-title":"Propensity score matched all comers population treated with ultra-thin strut bare metal and sirolimus-probucol coated drug-eluting stents of identical stent architecture","volume":"91","author":"Krackhardt","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"1753944719826335","DOI":"10.1177\/1753944719826335","article-title":"Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries","volume":"13","author":"Sperling","year":"2019","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Academic research consortium. Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Joint ESC\/ACCF\/AHA\/WHF task force for universal definition of myocardial infarction, authors\/task force members chairpersons, biomarker subcommittee, ECG subcommittee, imaging subcommittee, classification subcommittee, intervention subcommittee, trials & registries subcommittee, trials & registries subcommittee, trials & registries subcommittee, trials & registries subcommittee, ESC committee for practice guidelines (CPG), document reviewers. Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: The task force on myocardial revascularization of the European society of cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS) developed with the special contribution of the European association of percutaneous cardiovascular interventions (EAPCI)","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.jacc.2012.07.040","article-title":"SeQuentPlease World Wide Registry: clinical results of SeQuent please paclitaxel-coated balloon angioplasty in a large-scale, prospective registry study","volume":"60","author":"W\u00f6hrle","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ccd.26261","article-title":"A. Thin strut bare metal stents in patients with atrial fibrillation: is there still a need for BMS?","volume":"88","author":"Leschke","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"R12-20230915","doi-asserted-by":"crossref","DOI":"10.1002\/ccd.28076","article-title":"Predictors of clinical outcomes after coronary implantation of bioresorbable polymer sirolimus-eluting Ultimaster stents in all-comers: A report of 1,727 cases","author":"Tadano","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jcin.2017.02.024","article-title":"The devil is always in the details","volume":"10","author":"Hicks","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijcard.2019.01.040","article-title":"New-generation drug-eluting stents for unselected patients with left main coronary artery disease: crossing a second Rubicon?","volume":"280","author":"Alfonso","year":"2019","journal-title":"Int J Cardiol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/eurheartj\/ehy238","article-title":"Management of left main disease: an update","volume":"40","author":"Fajadet","year":"2019","journal-title":"Eur Heart J"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijcard.2018.12.003","article-title":"DELTA 2 Investigators. New-generation drug-eluting stents for left main coronary artery disease according to the EXCEL trial enrollment criteria: insights from the all-comers, international, multicenter DELTA-2 registry","volume":"280","author":"Tanaka","year":"2019","journal-title":"Int J Cardiol"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/ccd.28119","article-title":"IRIS-MAIN registry investigators. Long-term trends of treatment effect of stenting or bypass surgery in patients with ostial or shaft left main coronary artery disease","volume":"94","author":"Yoon","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"R18-20230915","first-page":"511","article-title":"Stent versus coronary artery bypass surgery in multi-vessel and left main coronary artery disease: a meta-analysis of randomized trials with subgroups evaluation","volume":"112","author":"Andrade","year":"2019","journal-title":"Arq Bras Cardiol"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/ejcts\/ezz142","article-title":"Coronary artery bypass confers intermediate-term survival benefit over percutaneous coronary intervention with new-generation stents in real-world patients with multivessel coronary artery disease, including left main disease: a retrospective analysis of 6383 patients","volume":"56","author":"Panoulas","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12872-017-0664-5","article-title":"Long-term outcomes of coronary artery bypass grafting versus stent-PCI for unprotected left main disease: a meta-analysis","volume":"17","author":"De Rosa","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcin.2017.10.024","article-title":"A Randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis: the DARE trial","volume":"11","author":"Baan","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"R22-20230915","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jcin.2018.02.037","article-title":"RIBS IV study investigators (under the auspices of the interventional cardiology working group of the spanish society of cardiology). 3-year clinical follow-up of the RIBS IV clinical trial: a prospective randomized study of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis in coronary arteries previously treated with drug-eluting stents","volume":"11","author":"Alfonso","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"R23-20230915","article-title":"Drug-eluting stents versus bare-metal stents for saphenous vein graft interventions: a systematic review and meta-analysis of studies with longer follow-up","author":"Garg","year":"2019","journal-title":"Curr Probl Cardiol"},{"key":"R24-20230915","doi-asserted-by":"crossref","first-page":"E193","DOI":"10.1002\/ccd.28011","article-title":"Treating saphenous vein graft lesions: drug-eluting stents are not the answer!","volume":"93","author":"Hall","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"R25-20230915","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/ccd.27687","article-title":"A comprehensive meta-analysis of randomized controlled trials comparing drug-eluting stents with bare-metal stents in saphenous vein graft interventions","volume":"92","author":"Shah","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"R26-20230915","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0140-6736(18)30801-8","article-title":"Banerjee S; DIVA trial investigators. Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double-blind, randomised trial","volume":"391","author":"Brilakis","year":"2018","journal-title":"Lancet"},{"key":"R27-20230915","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s00392-018-1392-2","article-title":"Incidence, predictors, and outcomes of DAPT disruption due to non-compliance vs. bleeding after PCI: insights from the PARIS Registry","volume":"108","author":"Moalem","year":"2019","journal-title":"Clin Res Cardiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T23:36:35Z","timestamp":1694820995000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019119","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2]]}}}